MD HB466 | 2019 | Regular Session

Status

Spectrum: Slight Partisan Bill (Democrat 24-8)
Status: Engrossed on March 15 2019 - 50% progression
Action: 2019-03-25 - Favorable Report by Finance
Text: Latest bill text (Engrossed) [PDF]

Summary

Requiring the Prescription Drug Monitoring Program to provide prescription monitoring data to authorized users, rather than the authorized administrator, of another state's prescription drug monitoring program; repealing the termination date of the Program; repealing the requirement that the Department of Legislative Services conduct a certain evaluation of the Program under the Maryland Program Evaluation Act; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drug Monitoring Program - Program Evaluation

Sponsors


Roll Calls

2019-03-12 - House - House Floor - Third Reading Passed (137-0) (Y: 138 N: 1 NV: 2 Abs: 8) [PASS]

History

DateChamberAction
2019-03-25SenateFavorable Report by Finance
2019-03-18SenateFirst Reading Finance
2019-03-15HouseThird Reading Passed (137-0)
2019-03-14HouseSecond Reading Passed with Amendments
2019-03-14HouseFavorable with Amendments {186782/1 Report Adopted
2019-03-14HouseFavorable with Amendments Report by Health and Government Operations
2019-02-08HouseHearing 2/20 at 1:00 p.m.
2019-02-01HouseFirst Reading Health and Government Operations

Subjects


Maryland State Sources


Bill Comments

feedback